Advertisement

Topics

Crohns & Colitis Foundation of America Company Profile

13:12 EDT 18th September 2018 | BioPortfolio

Crohn's disease, a chronic inflammatory disease of the gastrointestinal tract, affects approximately 500,000 Americans, including approximately 100,000 pediatric patients. The cause of Crohn's disease is not known, but the disease is associated with an abnormality of the immune system that could be triggered by viral or bacterial infections, a genetic predisposition or diet. Symptoms of Crohn's disease can vary but often include abdominal pain and tenderness, frequent diarrhea, rectal bleeding, weight loss and fever. There is currently no cure for Crohn's disease.


News Articles [802 Associated News Articles listed on BioPortfolio]

Vedanta Biosciences receives award to advance microbiome derived therapeutic programme

The PureTech Health affiliate has received funding from the Crohn's & Colitis Foundation, a non-profit organisation dedicated to finding the cures for Crohn's disease and ulcerative colitis

Organizers of the 2019 Crohn's & Colitis Congress announce agenda & call for abstracts

(American Gastroenterological Association) The Crohn's & Colitis Congress®, the premier meeting for clinical and research professionals in the IBD space, has opened registration for the 2019 meeting....

Fellowships offer reporters valuable insight as America ages

(The Gerontological Society of America) The Gerontological Society of America (GSA) Journalists in Aging Fellows Program has received renewed grant support to welcome its ninth cohort of reporters. Th...

Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to ...

Read more...

Ulcerative Colitis – 2018 Pipeline Highlights – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ulcerative colitis Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. ‘Ulcerative colitis Pip...

Tofacitinib (Xeljanz) Gets FDA Nod for Ulcerative Colitis

The FDA has expanded the indication for tofacitinib to include adults with moderate to severe active ulcerative colitis, making it the first oral medication approved for long-term use in ulcerative co...

Innovation Pharmaceuticals to Present Brilacidin for Inflammatory Bowel Disease at Inaugural “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis Foundation

BEVERLY, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that the Company has been...

Stool proteins to predict inflammatory bowel disease

(University of Houston) A University of Houston biomedical engineer is looking for new biomarkers to predict and monitor inflammatory bowel disease (IBD). With $347,490 from the Crohn's & Colitis Foun...

Drugs and Medications [735 Associated Drugs and Medications listed on BioPortfolio]

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

Shiseido white lucent brightening spot-control foundation (refill) [SHISEIDO AMERICA INC.]

SHISEIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill)

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

PubMed Articles [1113 Associated PubMed Articles listed on BioPortfolio]

Crohn's and Colitis Foundation of America Partners Patient-Powered Research Network: Patient Perspectives on Facilitators and Barriers to Building an Impactful Patient-Powered Research Network.

To build a patient-powered research network (PPRN) that prioritizes the needs of its members who have inflammatory bowel diseases (IBD), we sought to better understand patients' preferences for what a...

Inflammatory Bowel Disease in Latin America: A Systematic Review.

Inflammatory bowel disease (IBD) is the name given to two inflammatory diseases of the colon and/or small intestine: Crohn disease (CD) and ulcerative colitis (UC). There is no information summarizing...

The Florence Nightingale Foundation: developing nursing's leaders.

Ursula Ward, Chief Executive, Florence Nightingale Foundation, chiefexec@florence-nightingale-foundation.org.uk , describes the role of the foundation and its plans for the future.

Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?

Microscopic colitis (MC) has been described as 1 pattern of injury in immune checkpoint inhibitor (ICPI)-induced colitis. The main objective of this study was to characterize ICPI-induced MC by explor...

Functional characterization of oxazolone-induced colitis and survival improvement by vagus nerve stimulation.

Oxazolone-induced colitis has been frequently used in literature as a model of IBD, but insights into the underlying immune response and pathological features are surprisingly still very limited. Vagu...

Clinical Trials [1073 Associated Clinical Trials listed on BioPortfolio]

Atorvastatin in Moderate Active Crohns Disease

Open pilot study to collect information regarding the effect of atorvastatin on patients with active Crohns disease.

The Promotion Plan of Moxibustion on Ulcerate Colitis

To evaluate the efficacy of Moxibustion in the treatment of Ulcerative Colitis, thus the scientific foundation for rational use of Moxibustion in clinical usage, in order to find admission...

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohns Disease Who Have Been Previously Treated With Anti-TNF Therapy

A medical research study in adult patients who have moderate to severe Crohns disease designed to determine whether or not treatment with an experimental drug called ustekinumab (or CNTO12...

Risk Factors for Microscopic Colitis

Microscopic colitis is a common cause of watery diarrhea, particularly in the elderly. Although the incidence is comparable to ulcerative colitis and Crohn's disease, the etiology is unkno...

Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis

The purpose of this study is to evaluate the safety and tolerability of visilizumab in patients with severe ulcerative colitis that has failed to respond to steroid therapy. What is visil...

Companies [2303 Associated Companies listed on BioPortfolio]

Crohns & Colitis Foundation of America

Crohn's disease, a chronic inflammatory disease of the gastrointestinal tract, affects approximately 500,000 Americans, including approximately 100,000 pediatric patients. The cause of Crohn's diseas...

RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation (the Foundation) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The F...

The Crohn's & Colitis Foundation of America

Crohn's & Colitis Foundation of America

The Crohn's & Colitis Foundation of America is the largest non-profit, volunteer-driven organization dedicated to finding a cure for Crohn's disease and ulcerative colitis, and it ranks third among le...

Partnership for a Healthier America

The Partnership for a Healthier America is an independent, nonpartisan organization that will mobilize broad-based support for efforts to solve the child obesity challenge. Core a...

More Information about "Crohns & Colitis Foundation of America" on BioPortfolio

We have published hundreds of Crohns & Colitis Foundation of America news stories on BioPortfolio along with dozens of Crohns & Colitis Foundation of America Clinical Trials and PubMed Articles about Crohns & Colitis Foundation of America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Crohns & Colitis Foundation of America Companies in our database. You can also find out about relevant Crohns & Colitis Foundation of America Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...


Corporate Database Quicklinks



Searches Linking to this Company Record